Alumis Inc. Files 8-K, Formerly Esker Therapeutics
Ticker: ALMS · Form: 8-K · Filed: Mar 18, 2025 · CIK: 1847367
| Field | Detail |
|---|---|
| Company | Alumis Inc. (ALMS) |
| Form Type | 8-K |
| Filed Date | Mar 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, name-change
TL;DR
Alumis Inc. (formerly Esker Therapeutics) filed an 8-K on 3/18/25, confirming its HQ in South SF, CA.
AI Summary
On March 18, 2025, Alumis Inc. filed an 8-K report. The filing indicates the company's principal executive offices are located at 280 East Grand Avenue, South San Francisco, California. Alumis Inc. was formerly known as Esker Therapeutics, Inc. and FL2021-001, Inc., with name changes occurring on April 27, 2023, and February 22, 2021, respectively.
Why It Matters
This filing confirms Alumis Inc.'s corporate identity and address, providing essential information for investors and stakeholders regarding its operational base and historical name changes.
Risk Assessment
Risk Level: low — This filing is primarily administrative, confirming corporate details and past name changes, and does not introduce new financial or operational risks.
Key Players & Entities
- Alumis Inc. (company) — Registrant
- 280 East Grand Avenue, South San Francisco, California 94080 (location) — Principal executive offices
- Esker Therapeutics, Inc. (company) — Former company name
- FL2021-001, Inc. (company) — Former company name
- April 27, 2023 (date) — Date of name change
- February 22, 2021 (date) — Date of name change
FAQ
What is the exact date of the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing is March 18, 2025.
What is the principal executive office address of Alumis Inc.?
The principal executive office address of Alumis Inc. is 280 East Grand Avenue, South San Francisco, California 94080.
What was Alumis Inc. previously named?
Alumis Inc. was previously named Esker Therapeutics, Inc. and FL2021-001, Inc.
When did the name change from Esker Therapeutics, Inc. to Alumis Inc. occur?
The name change from Esker Therapeutics, Inc. occurred on April 27, 2023.
What is the SIC code for Alumis Inc.?
The Standard Industrial Classification (SIC) code for Alumis Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 18, 2025 regarding ALUMIS INC. (ALMS).